Your browser doesn't support javascript.
loading
Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma.
Blaes, Jonas; Thomé, Carina M; Pfenning, Philipp-Niclas; Rübmann, Petra; Sahm, Felix; Wick, Antje; Bunse, Theresa; Schmenger, Torsten; Sykora, Jaromir; von Deimling, Andreas; Wiestler, Benedikt; Merz, Christian; Jugold, Manfred; Haberkorn, Uwe; Abdollahi, Amir; Debus, Jürgen; Gieffers, Christian; Kunz, Claudia; Bendszus, Martin; Kluge, Michael; Platten, Michael; Fricke, Harald; Wick, Wolfgang; Lemke, Dieter.
Afiliación
  • Blaes J; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Thomé CM; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
  • Pfenning PN; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Rübmann P; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
  • Sahm F; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Wick A; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
  • Bunse T; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Schmenger T; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
  • Sykora J; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • von Deimling A; Department of Neuropathology, University Hospital of Heidelberg, Heidelberg, Germany.
  • Wiestler B; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Merz C; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
  • Jugold M; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Germany.
  • Haberkorn U; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Abdollahi A; Clinical Cooperation Unit Neuroimmunology & Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
  • Debus J; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Gieffers C; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
  • Kunz C; Apogenix AG, Heidelberg, Germany.
  • Bendszus M; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Kluge M; Department of Neuropathology, University Hospital of Heidelberg, Heidelberg, Germany.
  • Platten M; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Fricke H; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
  • Wick W; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Germany.
  • Lemke D; Apogenix AG, Heidelberg, Germany.
Mol Cancer Res ; 16(5): 767-776, 2018 05.
Article en En | MEDLINE | ID: mdl-29453321
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Inmunoglobulina G / Glioblastoma / Receptor fas / Proteína Ligando Fas Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: Mol Cancer Res Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Inmunoglobulina G / Glioblastoma / Receptor fas / Proteína Ligando Fas Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: Mol Cancer Res Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos